Longitudinal analysis of topographic VEP in relapsing-remitting patients with multiple sclerosis

被引：0
|
作者：
Hardmeier, M. [1 ]
Hatz, F. [1 ]
Hight, D. [2 ]
Naegelin, Y. [1 ]
Schindler, C. [3 ]
Kappos, L. [1 ]
Seeck, M. [4 ]
Michel, C. M. [5 ]
Fuhr, P. [1 ]
机构：
[1] Univ Basel Hosp, Neurol, CH-4031 Basel, Switzerland
[2] Univ Auckland Hamilton, Waikato Clin Sch, Anaesthesiol, Auckland, New Zealand
[3] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[4] Univ Hosp Geneva, Neurol, Geneva, Switzerland
[5] Univ Med Sch, Fundamental Neurosci, Geneva, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1013
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [41] Expression of fractalkine in plasma of patients with relapsing-remitting multiple sclerosis
    Pujari, S.
    Suliman, O.
    Woodroofe, N.
    Sharrack, B.
    MULTIPLE SCLEROSIS, 2006, 12 : S219 - S219
  • [42] Lymphocyte subpopulation in patients with relapsing-remitting multiple sclerosis and SPMS
    Belniak, E.
    Bojarska-Junak, A.
    Mitosek-Szewczyk, K.
    Bartosik-Psujek, H.
    Stehmasiak, Z.
    Rolinski, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S43 - S43
  • [43] Cognitive Impairment in Patients with Early Relapsing-Remitting Multiple Sclerosis
    Keklikoglu, Hava Doenmez
    Yoldas, Tahir Kurtulus
    Zengin, Oezkan
    Banu Solak, Elif
    Keskin, Selda
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2010, 47 (02): : 88 - 90
  • [44] Characteristics of verbal fluency in patients with relapsing-remitting multiple sclerosis
    Tyburski, E.
    Potemkowski, A.
    Chec, M.
    Soltys, A.
    Sokolowski, A.
    Kowalewski, M.
    Samochowiec, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 226 - 226
  • [45] Executive function and memory in patients with relapsing-remitting multiple sclerosis
    Cerezo Garcia, Marta
    Martin, Pilar
    Aladro Benito, Yolanda
    Balseiro Gomez, Jose Jesus
    Rueda Marcos, Almudena
    PSICOTHEMA, 2009, 21 (03) : 416 - 420
  • [46] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [47] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [48] Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro
    Erakovic, Jevto Lj
    Radulovic, Ljiljana B.
    Idrizovic, Zilha A.
    Roganovic, Milovan B.
    NEUROSCIENCES, 2021, 26 (04) : 331 - 338
  • [49] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [50] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
12345